Document Detail

Valsartan-amlodipine-hydrochlorothiazide: the definitive fixed combination?
MedLine Citation:
PMID:  21090936     Owner:  NLM     Status:  In-Process    
A significant proportion of patients with hypertension will need three or more antihypertensive agents to achieve blood pressure goals, particularly those at higher risk. On the other hand, fixed combinations provide an extra beneficial effect, as they improve medication adherence and, secondarily, the attainment of blood pressure goals during follow-up. Triple therapy is recommended in the treatment of hypertension in those patients not adequately controlled with two antihypertensive drugs. In this context, guidelines recommend the combination of a renin-angiotensin system inhibitor, a calcium channel blocker and a diuretic. The triple fixed combination of valsartan-amlodipine-hydrochlorothiazide has been shown to be an effective and safe therapy for treating hypertension and seems a logical approach for those patients uncontrolled with two antihypertensive agents as well as in those patients already treated with three drugs to improve treatment compliance. In this article, available evidence about the efficacy and tolerability of the triple fixed combined therapy valsartan-amlodipine-hydrochlorothiazide for the treatment of hypertension is updated.
Vivencio Barrios; Carlos Escobar
Related Documents :
2871856 - The pharmacological basis for the use of alpha 1-adrenoceptor antagonists in the treatm...
15333056 - Impact of educational mailing on the blood pressure of primary care patients with mild ...
15724796 - Education, motivation and medication for african americans: bringing hypertension guide...
16945056 - Coronary artery disease and hypertension: outcomes of a pharmacist-managed blood pressu...
4033356 - Effects of tranylcypromine treatment on neuroendocrine, behavioral, and autonomic respo...
25129876 - Comparison of accuracy of two different methods to determine ankle-brachial index to pr...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Expert review of cardiovascular therapy     Volume:  8     ISSN:  1744-8344     ISO Abbreviation:  Expert Rev Cardiovasc Ther     Publication Date:  2010 Nov 
Date Detail:
Created Date:  2010-11-24     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101182328     Medline TA:  Expert Rev Cardiovasc Ther     Country:  England    
Other Details:
Languages:  eng     Pagination:  1609-18     Citation Subset:  IM    
Department of Cardiology, Hospital Ramón y Cajal, Carretera de Colmenar Viejo, Km 9.100, 28034 Madrid, Spain.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Role of vitamin D in arterial hypertension.
Next Document:  Treating atherosclerosis: the potential of Toll-like receptors as therapeutic targets.